A Randomized Phase 3 Trial Of Melphalan-Lenalidomide-Prednisone (MPR) Or Cyclophosphamide-Prednisone-Lenalidomide (CPR) Vs Lenalidomide Plus Dexamethsone (Rd) In Elderly Newly Diagnosed Multiple Myeloma Patients

Konference: 2013 55th ASH Annual Meeting - účast ČR

Kategorie: Mnohočetný myelom

Téma: 653. Myeloma: Therapy, excluding Transplantation: Treatment Options for Newly Diagnosed Multiple Myeloma Patients

Číslo abstraktu: 536

Autoři: MD Antonio P. Palumbo; MD Valeria Magarotto; MD Sara Bringhen; M.D. Massimo Offidani; Giuseppe Pietrantuono; Prof. MD Anna Marina Liberati; Giulia Benevolo; Antonio Ledda; Milena Gilestro; MD Monica Galli, PhD; Francesca Patriarca; M.D. Mariella Genuardi; Prof. M.D. Nicola Giuliani; Renato Zambello; prof. MUDr. Zdeněk Adam, CSc.; M.D. Alessia La Fauci; M.D. Paolo Corradini; M.D. Antonietta Pia Falcone; prof. M.D. Caterina Musolino; M.D. Davide Rossi; M.D. Patrizia Caraffa; MD Pellegrino Musto; M.D. Federica Cavallo; prof. MUDr. Roman Hájek, CSc.; MD Mario Boccadoro

Datum přednesení příspěvku: 9. 12. 2013